Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted therapies in ameloblastomas and amelobastic carcinoma-A systematic review.

Oral diseases - 1 Sept 2024

Bologna-Molina Ronell, Schuch Lauren, Magliocca Kelly, van Heerden Willie, Robinson Liam, Bilodeau Elizabeth Ann, Hussaini Haizal Mohd, Soluk-Tekkesin Merva, Adisa Akinyele Olumuyiwa, Tilakaratne Wanninayake Mudiyanselage, Li Jiang, Gomez Ricardo Santiago, Hunter Keith David

Abstract excerpt

Targeted therapy has the potential to be used in the neoadjuvant setting for odontogenic tumors, reducing the morbidities associated with major surgery. In this regard, the aim of this study was to summarize the current evidence on the different forms of targeted therapy, effectiveness, and drawbacks of this course of treatment. Four databases were searched electronically without regard to publication date or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Imidazoles
Share to Jaw Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ameloblastoma

Share to Anilides

Share to Molecular Targeted Therapy

Share to Mutation

Share to Oximes

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 38693620
DOI: 10.1111/odi.14962

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted therapies in ameloblastomas and amelobastic carcinoma-A systematic review.PMID 38693620Read ↗

Effectiveness of molecular-targeted chemotherapy in ameloblastomas: A systematic review.Semantic proximity Read ↗

Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach.Semantic proximity Read ↗

Novel targets for the treatment of ameloblastoma.Semantic proximity Read ↗

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature.Semantic proximity Read ↗

Ameloblastoma: A succinct review of the classification, genetic understanding and novel molecular targeted therapies.Semantic proximity Read ↗

Molecular biology exploration and targeted therapy strategy of Ameloblastoma.Semantic proximity Read ↗

Exploiting BRAF mutations in the therapeutic approach towards oral and maxillofacial tumors.Semantic proximity Read ↗

Precision therapy for BRAF V600E-mutated ameloblastoma: Systematic review insights.Semantic proximity Read ↗

Progress towards personalized medicine for ameloblastoma.Semantic proximity Read ↗

BRAF inhibitor treatment of primary BRAF-mutant ameloblastoma with pathologic assessment of response.Semantic proximity Read ↗

Managing stage 4 ameloblastoma with dual BRAF/MEK inhibition: A case report with 8-year clinical follow-up.Semantic proximity Read ↗

BRAF V600E mutation-specific immunohistochemical analysis in ameloblastomas: a 44-patient cohort study from a single institution.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.